Chrysalis Biotherapeutics TP508 Acute Respiratory Virus Therapy Patent EP4132948A1
Summary
The European Patent Office published patent application EP4132948A1 titled 'TP508 Acute Therapy for Patients with Respiratory Virus Infection' on April 15, 2026. The patent application covers peptide-based therapeutic compositions and lists Chrysalis Biotherapeutics as the applicant with inventors Darrell Carney and Laurie Sower. The designated states for potential validation include all EPC contracting states across the European region. Patent publication does not constitute market authorization or clinical approval for the therapeutic indication described.
About this source
GovPing monitors EPO Patent Bulletin - Peptides (C07K) for new healthcare & life sciences regulatory changes. Every update since tracking began is archived, classified, and available as free RSS or email alerts — 58 changes logged to date.
What changed
The European Patent Office published patent application EP4132948A1 for Chrysalis Biotherapeutics' TP508 peptide composition as an acute therapy for respiratory virus infections. The application was published on April 15, 2026 with IPC classifications covering peptide sequences (C07K), viral proteins (C07K 14/165), and the therapeutic use (A61P 31/12). Designated states cover all major EPC contracting states including Germany, France, the United Kingdom, Italy, Spain, and other European jurisdictions.
Organizations developing peptide-based antiviral therapeutics should monitor this and similar patent publications for freedom-to-operate considerations. The patent publication represents an early-stage intellectual property filing and does not indicate clinical efficacy, safety approval, or regulatory authorization for the therapeutic indication described.
Archived snapshot
Apr 25, 2026GovPing captured this document from the original source. If the source has since changed or been removed, this is the text as it existed at that time.
TP508 ACUTE THERAPY FOR PATIENTS WITH RESPIRATORY VIRUS INFECTION
Publication EP4132948A1 Kind: A1 Apr 15, 2026
Applicants
Chrysalis Biotherapeutics, Carney, Darrell, Sower, Laurie, E.
Inventors
CARNEY, Darrell, SOWER, Laurie, E.
IPC Classifications
C07K 14/005 20060101AFI20231130BHEP C07K 14/165 20060101ALI20231130BHEP C07K 14/08 20060101ALI20231130BHEP A61K 38/48 20060101ALI20231130BHEP A61P 31/12 20060101ALI20231130BHEP
Designated States
AL, AT, BE, BG, CH, CY, CZ, DE, DK, EE, ES, FI, FR, GB, GR, HR, HU, IE, IS, IT, LI, LT, LU, LV, MC, MK, MT, NL, NO, PL, PT, RO, RS, SE, SI, SK, SM, TR
Related changes
Get daily alerts for EPO Patent Bulletin - Peptides (C07K)
Daily digest delivered to your inbox.
Free. Unsubscribe anytime.
Source
About this page
Every important government, regulator, and court update from around the world. One place. Real-time. Free. Our mission
Source document text, dates, docket IDs, and authority are extracted directly from EPO.
The summary, classification, recommended actions, deadlines, and penalty information are AI-generated from the original text and may contain errors. Always verify against the source document.
Classification
Who this affects
Taxonomy
Browse Categories
Get alerts for this source
We'll email you when EPO Patent Bulletin - Peptides (C07K) publishes new changes.
Subscribed!
Optional. Filters your digest to exactly the updates that matter to you.